UBS lowered the firm’s price target on Aramark (ARMK) to $45 from $46 and keeps a Buy rating on the shares. UBS sees a “tricky” setup for Aramark with several moving parts on growth and margins heading into the Q4 print, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK:
- Positive Growth Outlook for ARAMARK Holdings Despite Revenue Challenges
- Aramark Holdings Refinances Loans with New Agreement
- Soros boosts exits stake in AstraZeneca, cuts position in Alphabet
- ARAMARK Holdings: Strong Growth Prospects and Strategic Investments Justify Buy Rating
- Aramark price target raised to $46 from $44 at UBS